BIDE PHARMATECH CO., LTD. — Investor Relations & Filings
About BIDE PHARMATECH CO., LTD.
Bide Pharmatech Co., Ltd. specializes in the research, development, and supply of high-quality chemical building blocks and specialty reagents for the global pharmaceutical and biotechnology sectors. The company offers an extensive portfolio of small molecule organic compounds, including functionalized heterocycles, catalysts, ligands, and advanced intermediates essential for drug discovery and chemical research. Bide Pharmatech provides comprehensive services ranging from catalog product distribution to custom synthesis and contract research, supporting clients through various stages of the drug development lifecycle. With a focus on technical innovation and rigorous quality control, the firm facilitates efficient lead optimization and process development for academic institutions and commercial laboratories worldwide.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于向激励对象首次授予限制性股票的公告 | 2025-01-08 | Chinese | |
| 第二届董事会第十四次会议决议公告 | 2025-01-08 | Chinese | |
| 第二届监事会第十一次会议决议公告 | 2025-01-08 | Chinese | |
| 关于补选非独立董事、战略委员会委员暨聘任高级管理人员的公告 | 2025-01-08 | Chinese | |
| 上海君澜律师事务所关于毕得医药2024年激励计划首次授予限制性股票相关事项之法律意见书 | 2025-01-08 | Chinese | |
| 毕得医药：监事会关于2024年限制性股票激励计划首次授予激励对象名单的核查意见（截至授予日） | 2025-01-08 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
11 filings
| |||||
| 39489749 | 关于向激励对象首次授予限制性股票的公告 | 2025-01-08 | Chinese | ||
| 39489736 | 第二届董事会第十四次会议决议公告 | 2025-01-08 | Chinese | ||
| 39489730 | 第二届监事会第十一次会议决议公告 | 2025-01-08 | Chinese | ||
| 39489723 | 关于补选非独立董事、战略委员会委员暨聘任高级管理人员的公告 | 2025-01-08 | Chinese | ||
| 39489714 | 上海君澜律师事务所关于毕得医药2024年激励计划首次授予限制性股票相关事项之法律意见书 | 2025-01-08 | Chinese | ||
| 39489706 | 毕得医药：监事会关于2024年限制性股票激励计划首次授予激励对象名单的核查意见（截至授予日） | 2025-01-08 | Chinese | ||
| 39489697 | 关于2024年限制性股票激励计划内幕信息知情人买卖公司股票情况的自查报告 | 2025-01-06 | Chinese | ||
| 39489690 | 北京国枫律师事务所关于上海毕得医药科技股份有限公司2025年第一次临时股东大会的法律意见书 | 2025-01-06 | Chinese | ||
| 39489681 | 2025年第一次临时股东大会决议公告 | 2025-01-06 | Chinese | ||
| 39489673 | 海通证券股份有限公司关于上海毕得医药科技股份有限公司核心技术人员离职暨新增认定核心技术人员的核查意见 | 2025-01-03 | Chinese | ||
| 39489668 | 上海毕得医药科技股份有限公司监事会关于公司2024年限制性股票激励计划首次授予激励对象名单的审核意见及公示情况说明 | 2025-01-02 | Chinese | ||
|
2024
4 filings
| |||||
| 39489661 | 关于公司核心技术人员离职暨新增认定核心技术人员的公告 | 2024-12-31 | Chinese | ||
| 39489651 | 毕得医药：2025年第一次临时股东大会会议资料 | 2024-12-31 | Chinese | ||
| 39489628 | 毕得医药：2024年限制性股票激励计划（草案） | 2024-12-23 | Chinese | ||
| 39489611 | 上海君澜律师事务所关于毕得医药2024年限制性股票激励计划（草案）之法律意见书 | 2024-12-20 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of basic chemicals
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
20 Microns Limited
Produces ultra-fine industrial minerals and specialty chemi…
|
20MICRONS | IN | Manufacturing |
|
5E Advanced Materials, Inc.
Develops boron and lithium resources for a domestic supply …
|
FEAM | US | Manufacturing |
|
Aarti Industries Ltd
Global producer of benzene-based specialty chemicals and ph…
|
AARTIIND | IN | Manufacturing |
|
Aarti Surfactants Limited
Produces surfactants and specialty chemicals for global FMC…
|
AARTISURF | IN | Manufacturing |
|
ABA CHEMICALS CORPORATION
CDMO for advanced intermediates and active ingredients for …
|
300261 | CN | Manufacturing |
|
AB Igrene
Converts natural methane into hydrogen and solid carbon usi…
|
ABI | SE | Manufacturing |
|
ADVANCED ENERGY MINERALS LTD
Produces ultra-high purity alumina for batteries, LEDs and …
|
AEM | AU | Manufacturing |
|
Advanced Graphene Products Spolka Akcyjna
Manufacturer of large-area and flake graphene materials and…
|
GPH | PL | Manufacturing |
|
ADVANCE ZINCTEK LIMITED
Produces zinc and aluminum oxide powders for sunscreens, sk…
|
ANO | AU | Manufacturing |
|
AdvanSix Inc.
A diversified chemistry company producing essential materia…
|
ASIX | US | Manufacturing |
BIDE PHARMATECH CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58121/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58121 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58121 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58121 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58121}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BIDE PHARMATECH CO., LTD. (id: 58121)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.